1. Cordon-Cardo, C., Fuks, Z., Drobnjak, M., Moreno, C., Eisenbach, L. and Feldman, M. 1991. Expression of HLA-A, B, C, antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res.51:6372.
2. Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P. and Linsley, P. S. 1992. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell71:1093.
3. Arteaga, C. L., Hurd, S. D., Winnier, A. R., Johnson, M. D., Fendly, B. M. and Forbes, J. T. 1993. Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-β interactions in human breast cancer progression. J. Clin. Invest.92:2569.
4. Yagita, M., Seppo, A., Renkonen, O. and Saksela, E. 1993. Deacetylase activity of human tumor cells producing immunosuppressive amino sugars: its possible role in resistance to cell-mediated cytotoxicity. Cancer Res.53:5600.
5. Kiessling, R., Wasserman, K., Horiguchi, S., Kono, K., Sjoberg, J., Pisa, P. and Petersson, M. 1999. Tumor-induced immune dysfunction. Cancer Immunol. Immunother.48:353.